Phase 3 Trial to Evaluate the Efficacy and Safety of YYC506.

NCT04858308 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

554

Enrollment

INDUSTRY

Sponsor class

Conditions

Dyslipidemias

Interventions

DRUG: YYC506
DRUG: Control
DRUG: YYC506 Placebo
DRUG: Control Placebo

Sponsor

Yooyoung Pharmaceutical Co., Ltd.